Status
Conditions
Treatments
About
To identify the diagnostic and therapeutic approach (efficacy and toxicity) of patients with lymphoid malignant hemopathy who are managed in the hematology department.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
13,000 participants in 1 patient group
Loading...
Central trial contact
Gilles Salles, MD; Marion Choquet
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal